FRIDAY 08/05/2020
CUTANEOUS AND EXTRA-CUTANEOUS MELANOMAS
(OCULAR, MUCOSAL, ACRAL)
    Speakers
14.30 – 15.00 REGISTRATION  
15.00 – 15.15 Epidemiological Trends Mrs. Anna Demetriou

 

(Cyprus)

15.15 – 15.35 Challenges in Histopathological Diagnosis Dr. Konstantia Frangia-Tsivou

 

(Greece)

15.35 – 15.45 Discussion  
  OCULAR MELANOMA  
15.45 – 16.05 Disease Entity (Incidence, Aetiology, Risk Factors, Pathophysiology) and Diagnosis (Symptoms, Clinical Diagnosis, Diagnostic Procedures, Differential Diagnosis) Dr. Petros Aristodemou

 

(Cyprus)

16.05 – 16.35 Surgical Approach (Biopsy, Enucleation etc.) Mr. Mandeep Sagoo

 

(UK)

16.35 – 16.45 Discussion  
16.45 – 17.15 Coffee Break  
17.15 – 17.45 Management of Metastatic Disease (Chemotherapy, Immunotherapy, Targeted Agents, Radiotherapy, etc.) Dr. Josep Piulats

 

(Spain)

17.45 – 17.50 Discussion  
  MUCOSAL & ACRAL MELANOMAS  
17.50 – 18.10 (Incidence, Diagnosis, Staging, Treatment) Dr. Zoe Kordatou

 

(Cyprus)

18.10 – 18.30 TBC TBC
18.30 – 18.35 Discussion  
18.35 – 19.45 Opening Ceremony  
19.45 Cocktail  
SATURDAY 09/05/2020
CUTANEOUS MELANOMA
09.00 – 09.20 The Dermatologist Perspective

 

(include the truth about sun protection, Vit D and follow-up of high risk groups)

Dr. Paschalis Konstantinou (Cyprus)
09.20 – 09.25 Discussion  
09.25 – 09.45 Imaging modalities: Controversies and Development Dr. Chloe Symeonidou

 

(Cyprus)

09.45 – 09.50 Discussion  
09.50 – 10.20 Ocular Brachytherapy (Operative Techniques for Plaque Placement & Plaque Choice (I-125, Ru-106, Pd-103, Cs-131, etc.) Dr. Shahar Frenkel (Israel)
10.20 – 10.25 Discussion  
  MANAGEMENT OF CUTANEOUS MELANOMA  
10.25 – 10.45 Challenges in Surgery and the Role of the Surgeon Dr. Barbara Peric

 

(Ljubliana)

10.45 – 11.05 Update in Plastic and Reconstructive Surgery Dr. Georgia Koulermou

 

(Cyprus)

11.05 – 11.15 Discussion  
11.15– 11.45 Coffee Break  
11.45 – 12.05 Unlocking the Full Potential of Melanoma Management: The Nurse’s Role Dr. Andreas Charalambous

 

(Cyprus)

12.05 – 12.15 Discussion  
12.15 – 12.35 Melanoma & Nuclear Medicine: New Insights & Advances Dr. Ourania Deimetriadou

 

(Cyprus)

12.35 – 12.40 Discussion  
12.40 – 13.00 Precision Medicine: Molecular Pathology and Pharmacogenomics in Cypriot Melanoma Patients Dr. Andreas Hadjisavvas (Cyprus)
13.00 – 13.10 Discussion  
13.10 – 14.15 Lunch  
  PRACTICE CHANGING ADVANCES IN NEOADJUVANT/ADJUVANT THERAPIES FOR STAGE III MELANOMA  
14.15 – 14.45 Neoadjuvant/Adjuvant Targeted Therapies: Recent Developments and Future Perspectives Dr. Paul Nathan

 

(UK)

14.45 – 15.15 Neoadjuvant/Adjuvant Immunotherapy:

 

Recent Developments and Future Perspectives

TBC
15.15 – 15.25 Discussion  
  CURRENT MANAGEMENT OF METASTATIC CUTANEOUS MELANOMA  
15.25 – 15.55 Where to next with Targeted Therapies? Dr. Paul Nathan

 

(UK)

15.55 – 16.25 The Evolving Role of Immunotherapy: Mechanism of Action, Update on clinical Trials, Management of Side Effects TBC
16.25 – 16.35 Discussion  
16.35 – 17.05 Coffee Break  
17.05 – 17.25 Radiotherapy Advances in Treating Metastatic Melanoma Dr. Konstantinos Ferentinos

 

(Cyprus)

17.25 – 17.30 Discussion  
17.30 – 17.50 Recent Progress in Melanoma-Related Lymphedema: Prevention and Treatment Mr. Wouter Frank Hoelen

 

(Holland)

17.50 – 17.55 Discussion  
  WHAT ELSE CAN WE LEARN ABOUT MELANOMA  
17.55 – 18.25 Understanding and predicting the clinical response to Immune Checkpoint Blockade using immune cell transcriptomics Dr. Robert Watson
18.25 – 18.35 Discussion  
  LIVING BEYOND MELANOMA  
18.35 – 18.45 Emotional and Psychological Support Mr. Loucas Christodoulou

 

(Cyprus)

18.45 – 18.55 Survivorship Issues and Management Mr. Andreas Papageorgiou

 

(Cyprus)

18.55 – 19.05 Living Beyond Melanoma: The Patient’s Perspective Mrs. Agathi Skoutari
19.05 – 19.10 Discussion  
19.10 – 19.30 Round Table – Conclusions Dr. Simos Malas
Dr. Paul Nathan